Genetic testing

LexaGene Completes Analytical Studies for FDA EUA of COVID-19 Testing

Monday, October 25, 2021 - 12:45pm

LexaGene is in the process of completing the necessary work to have the FDA rule on authorizing the MiQLab for COVID-19 testing.

Key Points: 
  • LexaGene is in the process of completing the necessary work to have the FDA rule on authorizing the MiQLab for COVID-19 testing.
  • The following analytical studies were completed using multiple MiQLab Systems:
    Dr. Regan continued, This milestone should be viewed as having much broader implications than COVID-19 testing only.
  • Preparing our technology to be able to successfully collect the analytical COVID-19 data is arguably the hardest step in the EUA process.
  • Until the FDA grants LexaGenes system EUA for COVID-19 testing, all work using LexaGene instruments is classified as Research Use Only and cannot be used for human clinical diagnostics.

Fulgent Genetics to Announce Third Quarter 2021 Financial Results on Tuesday November 9, 2021

Monday, October 25, 2021 - 1:00pm

Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent Genetics or the company), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced that it will release its third quarter 2021 financial results after the market closes on Tuesday November 9, 2021.

Key Points: 
  • Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent Genetics or the company), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced that it will release its third quarter 2021 financial results after the market closes on Tuesday November 9, 2021.
  • The call can be accessed through a live audio webcast in the Investors section of the companys website, http://ir.fulgentgenetics.com , and through a live conference call by dialing (800) 367-2403 using the confirmation code 3277675.
  • An audio replay will be available in the Investors section of the companys website.
  • Fulgent Genetics is a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health.

New Survey Reveals Majority of Houston Residents Misinformed about Their Fertility Health

Thursday, October 21, 2021 - 6:13pm

The study of 1,000 Houston-area residents between 25-44 years old aims to shed light on their understanding and knowledge of their fertility.

Key Points: 
  • The study of 1,000 Houston-area residents between 25-44 years old aims to shed light on their understanding and knowledge of their fertility.
  • Surprisingly, nearly 75% of respondents admit to feeling "uninformed," "clueless" or only "somewhat knowledgeable" about their fertility health.
  • In addition to onsite, personal consultations, CCRM Fertility Houston offers informative and easy-to-use resources, such as CCRM TV fertility education videos.
  • CCRM Fertility Houston is located at 929 Gessner Rd, Suite 2300 in Houston, TX, 77024.

OFT Food Safety Lawyers File First Lawsuit In Massive Nationwide Salmonella Outbreak From Onions

Thursday, October 21, 2021 - 4:54pm

MINNEAPOLIS, Oct. 21, 2021 /PRNewswire/ -- OFT Food Safety & Injury Lawyers filed the first lawsuit in the multistate Salmonella outbreak linked to onions distributed by ProSource, Inc. and sold throughout the United States.

Key Points: 
  • MINNEAPOLIS, Oct. 21, 2021 /PRNewswire/ -- OFT Food Safety & Injury Lawyers filed the first lawsuit in the multistate Salmonella outbreak linked to onions distributed by ProSource, Inc. and sold throughout the United States.
  • OFT Food Safety Lawyers filed the first lawsuit in the Salmonella outbreak tied to onions distributed by ProSource, Inc.
    Advanced genetic testing known as Whole Genome Sequencing revealed that the Plaintiff in the case contracted outbreak strain of Salmonella, according to the Complaint.
  • OFT Food Safety Lawyer Ryan Osterholm praised the public health testing that revealed the source of the outbreak:
    Public health infrastructure is critically important to protecting our families from dangerous food.
  • With over 4 decades of experience, the lawyers at OFT Food Safety & Injury Lawyers have recovered millions on behalf of food poisoning victims.

Generate Life Sciences Details Data Presented at the 2021 Annual ASRM and AABB Meetings

Thursday, October 21, 2021 - 1:00pm

LOS ANGELES, Oct. 21, 2021 /PRNewswire/ -- Generate Life Sciences recently presented data from its research programs during this year's American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo and the AABB (formerly known as the American Association of Blood Banks) Annual Meeting.

Key Points: 
  • LOS ANGELES, Oct. 21, 2021 /PRNewswire/ -- Generate Life Sciences recently presented data from its research programs during this year's American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo and the AABB (formerly known as the American Association of Blood Banks) Annual Meeting.
  • "Constantly moving the research field forward is imperative for improving reproductive health services," said Kate Brown, Ph.D., Senior Director of Science at Generate.
  • All of our presented studies addressed fundamental questions that are vital for setting up future research."
  • Generate Life Sciences is a global life sciences company helping families setting out to grow and protect their future, through guidance anchored in scientific advancements and services ranging from preconception into adulthood.

Thirteen Ovation Research Abstracts Accepted for Presentation at ASRM 2021

Thursday, October 21, 2021 - 8:00am

Nashville, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Ovation Fertility teams are presenting three oral presentations and 10 poster presentations at the 2021 ASRM Scientific Congress & Expo, which takes place both virtually and in-personin Baltimore October 17-20, 2021.

Key Points: 
  • Nashville, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Ovation Fertility teams are presenting three oral presentations and 10 poster presentations at the 2021 ASRM Scientific Congress & Expo, which takes place both virtually and in-personin Baltimore October 17-20, 2021.
  • Additionally, Ovation scientists are leading interactive sessions and roundtable discussions at the annual event, where top experts in reproductive medicine discuss the latest in reproductive care.
  • The list of Ovation abstracts and presentations accepted for ASRM 2021 covers a wide range of groundbreaking findings in the fields of IVF, genetic testing, and the use of artificial intelligence in embryo selection.
  • Ovation also helps IVF labs across America improve their quality and performance with expert off-site lab direction and consultation.

Allison+Partners Bolsters Health Practice with Several Hires and Client Wins

Wednesday, October 20, 2021 - 2:53pm

Notable health client wins include Nordic Consulting , Perspectum , Talis Biomedical and veda.

Key Points: 
  • Notable health client wins include Nordic Consulting , Perspectum , Talis Biomedical and veda.
  • She will serve as the senior lead for the agencys growing health tech portfolio and several of the agencys new clients.
  • She also serves as the lead for the agencys health equity client offering.
  • In addition to the senior team, new hires for the health practice in 2021 include Maddie Wojtalewicz, Julia Palomino, Elizabeth Osunkwo and Lucy Neubeck.

Rhythm Pharmaceuticals to Report Third Quarter 2021 Financial Results on Tuesday, November 2, 2021

Wednesday, October 20, 2021 - 1:00pm

About Rhythm PharmaceuticalsRhythm is a commercial-stage biopharmaceutical company committed to transforming the treatment paradigm for people living with rare genetic diseases of obesity. Rhythm’s precision medicine, IMCIVREE (setmelanotide), was approved in November 2020 by the U.S. Food and Drug Administration (FDA) for chronic weight management in adult and pediatric patients 6 years of age and older with obesity due to POMC, PCSK1 or LEPR deficiency confirmed by genetic testing and in July and September 2021, respectively, by the European Commission (EC) and Great Britain’s Medicines & Healthcare Products Regulatory Agency (MHRA) for the treatment of obesity and the control of hunger associated with genetically confirmed loss-of-function biallelic POMC, including PCSK1, deficiency or biallelic LEPR deficiency in adults and children 6 years of age and above. IMCIVREE is the first-ever FDA-approved and EC- and MHRA-authorized therapy for patients with these rare genetic diseases of obesity. Rhythm is advancing a broad clinical development program for setmelanotide in other rare genetic diseases of obesity and is leveraging the Rhythm Engine and the largest known obesity DNA database -- now with approximately 37,500 sequencing samples -- to improve the understanding, diagnosis and care of people living with severe obesity due to certain genetic deficiencies. Rhythm’s headquarters is in Boston, MA.

Key Points: 
  • ET on Tuesday, November 2, 2021 to report its third quarter 2021 financial results and provide a corporate update.
  • To access the live conference call, please dial (844) 498-0570 (domestic) or (409) 983-9726 (international) and refer to conference ID 2167009.
  • A webcast of the call will also be available under Events & Presentations in the Investor Relations section of the Rhythm website at ir.rhythmtx.com.
  • Rhythm is a commercial-stage biopharmaceutical company committed to transforming the treatment paradigm for people living with rare genetic diseases of obesity.

FDA Authorizes New Saliva Sample Collection Method for High-Throughput, Automated COVID-19 Testing System

Monday, October 18, 2021 - 1:00pm

SDNA saliva collection devices are self-contained systems that provide sample consistency and long-term stability while protecting DNA and RNA transcripts post-collection to help ensure accurate test results with only two milliliters of saliva.

Key Points: 
  • SDNA saliva collection devices are self-contained systems that provide sample consistency and long-term stability while protecting DNA and RNA transcripts post-collection to help ensure accurate test results with only two milliliters of saliva.
  • The Amplitude Solution gives laboratories the ability to scale COVID-19 PCR testing and process up to 8,000 samples in a single day.
  • The Amplitude Solution is a molecular diagnostic system that empowers clinical labs to expand testing capacity with minimal hands-on time, equipment and staffing.
  • Its high-throughput capabilities can be flexed to address testing needs for companies, schools, universities and communities to help them return to pre-pandemic life.

Myriad Genetics Names Pamela Wong as Chief Legal Officer

Monday, October 18, 2021 - 12:05pm

SALT LAKE CITY, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of Pamela Wong as its new Chief Legal Officer.

Key Points: 
  • SALT LAKE CITY, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of Pamela Wong as its new Chief Legal Officer.
  • She will report directly to Paul J. Diaz, president and CEO of Myriad Genetics.
  • Prior to joining Myriad Genetics, Wong spent 14 years with Quest Diagnostics, most recently as its Assistant General Counsel.
  • We are fortunate to have a talented legal professional of her caliber as the latest addition to the Myriad Genetics executive team.